ASCVD risk assesment Checklist before Statin tx

ACC: ASCUD risk estimator

#
plus (for whitedafrican-american) #e msouswpwisod

-low 10
year risk for ASCUD &rovitare in tuoiotous 4-12 was

Low-risk Lifestyle FlUg3-12 (cii target

g1 year)
<5: mod. & month -

orderline (5.7.4)
B (nt. (7.5-10.9) Twin
& target: F/Ug3 month & lifestyle rowdius

High I20 r. .
high intensity station 20,500
#
liver en2. (ASTIOALTS

Thai CV
# risk score (for that people) &rowide, or you baselines

low risk <100.int-high? 10% xusidapovis 4-12whs Ivii hepatotoxicity (

-
by age/Ind/ smoking DM/SBP ↓FlU lowc:doinswawir

MDL/LDL/TO
+

to soulos sown &

<ox of UN:
usar & unend

SCORE (for #3 CK
#
Europe 0300

lousilaa myalgia,
region lage/Ind smoking a mass
->
live

WOIrm SBP+Tchol

(ESCUDeverthe
-> Is pt InVIOw ASCUD, DM1-11, T ha; 2016 RCPT: Noir ACCVAUA
CASCUD>12M0.7
R0(k)
* 25: nod

family hypercholesterolemia 2 prevention w/ Clinical ASCUD

SCORE"
~

Pirros UrildT Target LDL-C <T/ dLDL5OY.

I It: hightmod statin

2018 ACCIAMA: Nv 4gr. Mortare station therapy an end: + Ezetinibe or

Cholestyramine

2) prevention for 1
age(2n + Clinical ASCUD 1 prevention 2 Normal (NO CRD/DM)

CINOW atherosclerotic Target (DL<130 (UniOwFH <100)

ACS, MI, stable/TIA, PAD On
origin
breath

LDL? 190: station

very high risk
# &
&
I made
Twini target
high
age 721
↓ month

Multiple
& ASCUD FHRLDL=190:
↓ R high statin E C
Twini target

x Major risks ↓CDL<1908 Risk 10U.:I lowned station

& age? 35

souasion Risk <10+wr

& plague/ high CAC

LDL -

c=c8

High statin Iezetimibe carnaisal

~ 6 month

T2vIVC

VHR
High Station [ ezetimibe: PCSKCi 3 With DM: Target viol (DL-c>100

age > 75: Now mod-high kinw high Toifvriot A

ge?4 LDL>190:
high statin

1 prevention for age 40-75 w/ LDL? 190: mod statin

2(DL-cF10 (ioo high station fuLDL <100 W stating of non-MDL Trai

- Tw + Ezetimibe 10
mg OD Target non-HDL</30

-> virion Inidontuos + BAS in fasting To 1300 f

R intensity statin I Fibrates

Paska; remer TwTr w/lifestyle change vous

BAS
Age <4
+
(DL>100

3 DM + (D1 276-190
- xida moderate statin Aware Risk factors 12 No: Mod, 0.1: Lowined

x nordion 10
years ASCUD Smoking HT proteinuria FN premature heart disease

· RW multiple ASCUD risks a

high statin

- is risks? 201. + Ezetimibe ↑ with CRD: Target LDL<100

age>75 nine statin Torra, visitates a rish/benefit Dialysis ripe station

ofPodio Tainrosido

age 20-35 w/risk enhancers on station matocason 2 CFR <60 & TirionTM:
LCRD3-5) Age? 50, LDL>100
low/mod Station 1 Ezetimibe

T2DMC 1 yrs/TIDM albuminuria

(2-30ng) ~ albumiuria>30 &eGFR260: Onstatin Unan
L(kD 1 -
2)

eGFR<68 retinopathy neuropathy

ABI <0.C (noodisonur/vou(
-
↑ risk -2.5+(D1-270-190:
woomonwwisol,
via
& lifestyle now unions condion in
-
age 0.10 W/ FM hyperchole start station -

o
age 20-39 w/ premature ASCUD8LDL 2160
& Soi18w wo -

age 40.75?20r.: high statin 4

wo.low risk brow High statin E:

201.w/
5 rish enhancer: God statin

victories of Coronary artery Ca"(plaque -

↓I - risk t
2019 ESCIEAS overview laska
↑ Chol ctrl
I
#
strategy
# Uo:ldw CUrisk on ISCORES 2
#
&or high-intensity station & dose againston to reach goal (As

& 101: baseline LDL-C

3
#
-
Rastator wastes + ezetimibe(IB) or BAS (lb,c

2
# worsen inalisedumipc 1 prevention (high risk, who FH) -
riccouwwiwin+ PCSKCi clss

" LDL-C 20 prevention (high risks -

ricdouwwiwin+ Paskci cons

SCORE
*
high-risk FH -
riccouwwiwin+ PCSKCi <1c

pt
& nfestation Totoios pi ezetimibe PCSKCi (116,0
↓ I (2)

baseline
3 Treatment goal: (DL.C? 500. On
#
doroa

1: Zain ...
T6 ctrl: To coin
lifestyle mod. TWTi, PCV risk I5 TOL 150

116 no SCOREC1: Station

& -
R of choice Ow pt no TC<200 LIB)

N/SCORE high Iwirif

Y
108 & risk pt w/T6 135-4CC icosapentethyl x2 (l1a,B)
1-5:
2g
condition of e
L NON SCORE 5-10 :. old disclos
·

dischemic event, ITo omron Crevent intridowoc To rid

5
5 NON SCORE? 10V 1 prevention ILDL is goal 15 T6>200 +
fens, benzafibrate (0,B)

& high risk pt ((1b, 2)

Recommended
-
- no Ow pt mind ASCrD event in within 2
yrs ccu risks

2 Tx (Non
goal UDL-2 @ Apo-B & TO (nrw> 200) FM : Familial dyslipidemia High

o Aic: PDM
nosgat <7% +ASCUD/ major risk factors
Very high e
goal (DL<55

iiritain
& target 1 PCSUCi

*pen proper diet

+ statin & 8.10 yrs old-goal (DL<135&10+yrs old

Ages 65 in station incontrolabor (IAs Female w/preg, lactation Twilwii Lipid-lowering agent
cririsons

↓ for 10 prevention winifoage 75 (In) o

1 severe FH a P BAS c.Taiwisons or LDLapheresis
usoo:Purtaci pt. high risk (lb, BC

io
& statin low dose+ dory titrate stroke pt r x of ischemic stroke, TIA a
Very high

need renal impairment, a DI tx: intensive LDL-C lowering

therapy

DM T 2DM:
High LDL goal <%0, Very high LDL
goal (55 Acs P high-dose station to soda Trimosa baseline

TIDM: High Very high likely statin target (LDL-CL-50%. &CDL <55 (monitor nostric 4-6wks)

uwinidrviu dose
* statin rouli combination of ezetimibe &nivitoitor target +
ezetimibe, pasuci dvoor

CKD
stage 3-5 (e6FR<63) High Very high

inwonton Our
# statin + ezetimibe

#riprocitors worta Proioci esp. PEWASCID

Zilwinpuion station niwonton & windfa